Cadila Stock Jumps To Highest In Nearly Three Years After Q2 Results
Finished tablets cascade down the channels of a packaging machine during the manufacture of the Favipiravir antiviral medicine at a plant in Khimki, Russia. (Photographer: Andrey Rudakov/Bloomberg)

Cadila Stock Jumps To Highest In Nearly Three Years After Q2 Results

Shares of Cadila Healthcare Ltd. jumped to the highest in nearly three years after the drugmaker reported a fourfold jump in quarterly net profit on a rise in sales in all key markets, including th...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.